Back
Pampa Energía SA Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison
Buy
71
PAM
Pampa Energía SA
Last Price:
$89.34
Seasonality Move:
2.11%
Sell
23
RARE
Ultragenyx Pharmaceutical, Inc.
Last Price:
$33.50
Seasonality Move:
-0.96%
Buy
71
Pampa Energía SA (PAM)
is a Buy
Is Pampa Energía SA a Buy, Sell or Hold?
-
The current Pampa Energía SA [PAM] share price is $89.65. The Score for PAM is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
-
PAM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Ultragenyx Pharmaceutical, Inc. (RARE)
is a Sell
Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?
-
The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $33.50. The Score for RARE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
RARE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PAM Stock Price Chart
What is Pampa Energía SA's stock price today?
-
The Pampa Energía SA share price today is $89.65Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PAM is experiencing slight buying pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical, Inc.'s stock price today?
-
The Ultragenyx Pharmaceutical, Inc. share price today is $33.50Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight buying pressure.
PAM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 16.7 | Buy |
| Relative Strength Index (14 RSI): | 56.34 | Buy |
| Chaikin Money Flow: | 44555 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (87.42 - 90.74) | Buy |
| Bollinger Bands (100): | (62.73 - 86.31) | Buy |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.24 | Buy |
| Relative Strength Index (14 RSI): | 45.54 | Sell |
| Chaikin Money Flow: | 579058 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.65 - 35.95) | Sell |
| Bollinger Bands (100): | (29.19 - 34.19) | Buy |
PAM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 89.11 | Buy |
| 20-day SMA: | 89.17 | Buy |
| 50-day SMA: | 82.28 | Buy |
| 200-day SMA: | 74.83 | Buy |
| 8-day EMA: | 47.03 | Buy |
| 20-day EMA: | 23.01 | Buy |
| 50-day EMA: | 10.03 | Buy |
| 200-day EMA: | 2.62 | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.82 | Sell |
| 20-day SMA: | 34.8 | Sell |
| 50-day SMA: | 33.74 | Sell |
| 200-day SMA: | 33.57 | Sell |
| 8-day EMA: | 17.59 | Buy |
| 20-day EMA: | 8.61 | Buy |
| 50-day EMA: | 3.75 | Buy |
| 200-day EMA: | 0.98 | Buy |
Pampa Energía SA Earnings Growth & PAM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.53 per share, and an increase next year of $4.48 per share.
Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.
Pampa Energía SA Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||